An Australian Study of Mesenchymal Stromal Cells for Crohn's Disease
This study has been completed.
The Queen Elizabeth Hospital
Sir Charles Gairdner Hospital
Information provided by (Responsible Party):
R.P.Herrmann, Royal Perth Hospital
First received: March 22, 2010
Last updated: June 7, 2015
Last verified: June 2015
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||June 2015|
|Primary Completion Date:||June 2014 (Final data collection date for primary outcome measure)|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Forbes GM, Sturm MJ, Leong RW, Sparrow MP, Segarajasingam D, Cummins AG, Phillips M, Herrmann RP. A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn's disease refractory to biologic therapy. Clin Gastroenterol Hepatol. 2014 Jan;12(1):64-71. doi: 10.1016/j.cgh.2013.06.021. Epub 2013 Jul 19.